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Protein-directed ribosomal frameshifting
temporally regulates gene expression
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Programmed  1 ribosomal frameshifting is a mechanism of gene expression, whereby
speciﬁc signals within messenger RNAs direct a proportion of translating ribosomes to shift
 1 nt and continue translating in the new reading frame. Such frameshifting normally occurs
at a set ratio and is utilized in the expression of many viral genes and a number of cellular
genes. An open question is whether proteins might function as trans-acting switches to turn
frameshifting on or off in response to cellular conditions. Here we show that frameshifting
in a model RNA virus, encephalomyocarditis virus, is trans-activated by viral protein 2A.
As a result, the frameshifting efﬁciency increases from 0 to 70% (one of the highest known in
a mammalian system) over the course of infection, temporally regulating the expression
levels of the viral structural and enzymatic proteins.
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P
rogrammed  1 ribosomal frameshifting ( 1 PRF) is
utilized in the expression of many viral genes and a number
of cellular genes1–3. It may also play a widespread role
in ﬁne-tuning gene expression via the stimulation of nonsense-
mediated mRNA decay pathways4. Sites of  1 PRF generally
comprise a ‘slippery’ sequence (at which the change in reading
frame occurs) and a 30-adjacent stimulatory mRNA structure. In
eukaryotes, the slippery sequence ﬁts a consensus heptanucleotide
motif X_XXY_YYZ, where XXX is any three identical nucleotides
(although certain exceptions occur, such as GGU); YYY repre-
sents AAA or UUU; Z represents A, C or U; and underscores
separate zero-frame codons5. In the tandem slippage model, the
ribosomal P-site tRNA anticodon re-pairs from XXY to XXX, and
the A-site anticodon re-pairs from YYZ to YYY, thus allowing
perfect re-pairing except at wobble positions6. The efﬁciency of
PRF is inﬂuenced by the identity of the slippery site nucleotides
but is normally less than 1% in the absence of additional
stimulatory elements. Thus, most known instances of eukaryotic
 1 PRF are stimulated (typically to a level of 5–45%, depending
on the particular case) by the presence of a 30 stable RNA
structure, such as a pseudoknot or stem–loop, separated from the
slippery heptanucleotide by a ‘spacer’ region of 5–9 nt. Structures
of this type are thought to be located at the mRNA unwinding
site of the ribosome entrance channel when their stimulatory
effect is exerted7. How the stimulatory RNAs function to
promote  1 PRF is still uncertain, but accumulating evidence
from prokaryotic counterparts indicates that the RNA structure
impedes back rotation of the ribosomal small subunit, trapping
the ribosome in a rotated or hyper-rotated state8,9. This stalled
state can be resolved either via spontaneous unwinding of the
structure or via a  1 PRF, which, by repositioning the structure
within the mRNA entrance channel, allows for more efﬁcient
unwinding by the ribosome9.
Like other members of the family Picornaviridae, encephalo-
myocarditis virus (EMCV; genus Cardiovirus) has a single-
stranded RNA genome of positive polarity, which also serves as
an mRNA. The genome is polyadenylated but lacks a 50 cap and
translation initiation is mediated by an internal ribosome entry
site (IRES) within the lengthy 50 UTR10. There is a single long
open reading frame whose translation produces a polyprotein
that is proteolytically cleaved, mainly by the virus-encoded 3C
protease, to produce the structural and enzymatic proteins
(Fig. 1a). For more than 50 years, EMCV has been used as a
model system for investigating molecular virology, virus–host
interactions and eukaryotic protein synthesis11–13. Studies of
EMCV, besides poliovirus and foot-and-mouth disease virus, also
led to the discovery of internal ribosome entry and StopGo co-
translational separation, with the former now thought to be
relevant for some key cellular genes and the latter an important
tool in biotechnology10,14–16. Recently, we uncovered a further
unusual aspect of EMCV translation, namely that a previously
undetected  1 PRF site in an internal region of the polyprotein
ORF directs a proportion of ribosomes into a short overlapping
ORF resulting in the production of a ‘trans-frame’ protein, 2B*
(Fig. 1a)17. Our previous work suggested that the PRF mechanism
in EMCV, and its relative Theiler’s murine encephalomyelitis
virus (TMEV), is atypical due to the apparent absence of an
appropriately positioned stimulatory RNA structure, and a failure
to reconstiute PRF outside of the context of virus infection17,18.
Here, we describe the discovery of a protein trans-activator of
EMCV frameshifting, viral protein 2A. We show that 2A binds to
an RNA stem–loop beginning 14 nt downstream of the slippery
sequence, forming an RNA:protein complex that induces highly
efﬁcient PRF. Through ribosome proﬁling, we investigate protein
synthesis in the natural context of EMCV infection and ﬁnd,
remarkably, that frameshifting is temporally regulated, increasing
from negligible levels at early time-points of infection to an
efﬁciency ofB70% at late time-points. Thus, frameshifting serves
as a control mechanism to modulate the relative levels of viral
structural and non-structural protein synthesis during the
replicative cycle. At early time points, ribosome progression to
the replicase coding sequences at the 30 end of the genome is
uninterrupted, but, as the replication cycle proceeds, frameshift-
ing progressively diverts ribosomes from the polyprotein ORF to
the overlapping 2B* ORF, downregulating replicase translation.
These experiments identify and elucidate a mechanism whereby
the efﬁciency of PRF can be temporally regulated, in contrast
to the ﬁxed efﬁciency levels of canonical  1 PRF.
Results
Ribosome proﬁling shows a temporal shift in PRF efﬁciency.
To investigate PRF efﬁciency in the context of virus infection,
we used ribosome proﬁling (Ribo-Seq) to directly monitor the
density of ribosomes upstream and downstream of the frameshift
site. Ribosome proﬁling is a recently developed technique that
enables global footprinting of translating ribosomes in cells via
high-throughput sequencing of ribosome-protected fragments
(RPFs) (Fig. 1b)19,20. We infected murine L929 cells with wild-type
(WT) or shift site mutant (SS) viruses and harvested cells at 2, 4, 6
and 8 h post infection (p.i.). In the SS mutant, the WT shift site
G_GUU_UUU is mutated to A_GUG_UUU (Fig. 1c) to inhibit
PRF17. Ribo-Seq libraries were prepared from each sample, deep
sequenced, and the resulting reads mapped to host and viral
genomes. Ribo-Seq quality was assessed as described previously
(Supplementary Fig. 1)21.
Figure 1d shows the distributions of RPFs on the WT and SS
virus genomes at 4 and 8 h p.i. (see Supplementary Fig. 2a for
2 and 6 h p.i.). For WT virus, a substantial decrease in mean
ribosome density was observed to occur after the 2B* ORF at
6 and 8 h p.i., indicating that the majority of ribosomes
translating the viral genome frameshift into the 2B* ORF and
terminate at the 2B* stop codon. For the SS mutant, however,
there is no signiﬁcant drop in RPF density at the 2B* stop codon,
consistent with inhibited frameshifting in this mutant. PRF
efﬁciencies were estimated from the WT ratio of downstream to
upstream RPF densities, normalized by the SS mutant to control
for variation in translational speed, technical biases and ribosome
pausing between different genomic locations. PRF efﬁciencies
were not obviously different from zero at 2 and 4 h p.i., but
at 6 and 8 h p.i. were remarkably high, at 64% and 69%,
respectively (Fig. 1e and Supplementary Fig. 2b). Consistent with
the absence of measurable PRF at 2 and 4 h p.i., a noticeable
ribosomal pause that was observed in the 2B* region at 6 and 8 h
p.i. for WT virus, is absent at 2 and 4 h p.i. and in the SS mutant
(Fig. 1d and Supplementary Fig. 2a). The effector of this pause is
uncertain though, in common with many other ribosomal pauses,
it may be nascent peptide mediated. Extraordinarily, from 6 h p.i.
RPFs accumulated to high levels on the mutated shift site (Fig. 1d
and Supplementary Fig. 2a). In contrast, only a modest
accumulation was apparent on the WT shift site. The position
of RPFs in this region indicate that the pause initiates when the
UUU of the shift site is in the ribosomal A-site and, in these
samples, continues for B3 codons thereafter (Supplementary
Fig. 2c,d), although such broadening of the pause is likely an
artefact resulting from ribosome run-on during sample prepara-
tion22. The total excess accumulation of RPFs over these four
codons at 6 and 8 h p.i. relative to 4 h p.i. isB5-fold greater in SS
than in WT.
Ribosome proﬁling of eukaryotic systems typically has the
characteristic that mappings of the 50 end positions of RPFs to
coding sequences reﬂect the triplet periodicity (herein referred to
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as ‘phasing’) of genetic decoding. Figure 1f and Supplementary
Fig. 2e show the polyprotein-frame codon positions to which
the 50 ends of RPFs map for regions upstream of 2B*, within 2B*,
and downstream of 2B*. For the upstream and downstream
regions, RPF 50 ends map mainly to the ﬁrst and third positions
of polyprotein-frame codons. In contrast, within the 2B* region,
RPF 50 ends for WT virus at 6 and 8 h p.i. map mainly to the
third and second positions of polyprotein-frame codons,
consistent with a mixture of ribosomes translating the two
overlapping reading frames in this region. For the SS mutant,
there is no change in the phasing of RPF 50 end positions in
the overlap region (Fig. 1f), consistent with inhibited PRF in
this mutant.
An RNA stem–loop is essential for PRF and ribosome pausing.
Previously, a downstream stem–loop structure, separated from
the frameshift site by a 13-nt ‘spacer’, was identiﬁed bioinfor-
matically17. This positioning is inconsistent with canonical
mRNA structure stimulators of  1 PRF, which are separated
from the shift site by just 5–9 nt. The predicted stem–loop is
conserved in different isolates of EMCV and in TMEV, with
compensatory substitutions (i.e. paired substitutions that preserve
the predicted base-pairings) further supporting its biological
relevance (Supplementary Fig. 3a). RNA structure probing
also supported the stem–loop (Supplementary Fig. 3b,c). To
assess a role for the stem–loop in PRF and/or ribosome pausing,
we generated a stem–loop mutant virus, WT-SL, and a corres-
ponding shift site mutant, SS-SL, and performed ribosome
proﬁling at 8 h p.i. (Fig. 2a,b; see Supplementary Fig. 4 for
Ribo-Seq quality assessment and Supplementary Fig. 5 for
corresponding RNA-Seq data). Pausing at the mutated shift site
(SS) was absent in the stem–loop mutant (SS-SL), showing that
the stem–loop is required for pausing. Assuming an average
translation speed20 of 0.18 s codon 1, the excess accumulation
of RPFs in SS (Fig. 2c) equates to a ribosomal pause of B20 s
(albeit with certain caveats; see Methods). For SS, WT-SL and
SS-SL viruses, there was no marked change in RPF phasing in the
overlap region (Fig. 2d), consistent with inhibition of PRF.
The PRF efﬁciency was measured as 70% for WT virus, but
negligible for the SS, WT-SL and SS-SL mutants (Fig. 2e). Thus
the stem–loop is essential for efﬁcient PRF.
The EMCV frameshift signal is located just downstream of the
junction between the 2A- and 2B-encoding regions of the
polyprotein ORF (Figs 1a and 2a). Separation between 2A and 2B
occurs co-translationally via a mechanism known as ‘StopGo’ or
‘Stop-Carry On’ that depends critically on the amino acid motif
D(V/I)ExNPGP (where the last proline is the ﬁrst amino acid of
2B)15,16. To assess whether StopGo affects PRF, we applied
ribosome proﬁling to viruses LV-WT and LV-SS-SL in which
StopGo was inhibited by mutating the NPGP sequence to NPLV
(Fig. 2a,b)23. For LV-WT, RPF phasing in the overlap region was
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not greatly different from WT (Fig. 2d), and the calculated PRF
efﬁciency (62%) was only slightly lower than WT (70%) (Fig. 2e).
The modest difference may be due to slower replication in
the mutant leading to a lag in achieving maximum PRF efﬁciency,
or may indicate a more direct (albeit modest) stimulatory effect
of StopGo on PRF, likely related to proper processing of the
C terminus of 2A (see below). On the other hand, for the mutant
LV-SS-SL these features were similar to the SS-SL mutant.
Thus we found no evidence for ribosome drop-off induced by
StopGo alone.
Virus protein 2A binds the RNA stem–loop. Having observed
that PRF in EMCV increases from 0 to 70% over the course
of infection and depends critically on an RNA stem–loop
structure positioned unusually far 30 of the frameshift site, we
reasoned that some virus-induced trans-acting protein might
interact with the stem–loop to promote PRF. To test this, we
used the RiboTrap system in which RNA transcripts are labelled
with 5-bromo-uridine to allow immunopuriﬁcation of
bound complexes. A short RNA transcript containing the
EMCV stem–loop was found to bind an B16 kDa protein from
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EMCV-infected cell lysates that was not observed with
mock-infected cell lysates or with a control RNA containing
a scrambled version of the EMCV stem–loop sequence
(Supplementary Fig. 6a). Mass spectrometric analysis of this
product revealed it to be the viral protein 2A (Fig. 1a and
Supplementary Fig. 6b).
To conﬁrm this interaction, we expressed and puriﬁed
recombinant 2A protein and performed electrophoretic
mobility shift assays (EMSAs) with a 64-nt 32P-labelled RNA
containing the EMCV frameshift site and stem–loop. Two main
RNA:protein complexes were observed, with the more slowly
migrating species accumulating as the amount of 2A was
increased (Fig. 3a), conﬁrming that 2A does indeed bind the
EMCV PRF signal. We estimated the Kd of the interaction
to be B3–4.5mM (Fig. 3b). A CCC triplet in the RNA loop
is highly conserved between different isolates of EMCV and
TMEV (Supplementary Fig. 3a), suggesting a potential role in
2A binding. To investigate this, we mutated the middle C to U
(C46U; Fig. 3c) and tested whether cold WT RNA or cold mutant
RNA could compete with the 32P-labelled WT RNA for 2A
binding. Whereas the WT RNA was able to compete well,
greatly diminishing radiolabelled RNA:protein complexes at
increasing molar excess, the C46U mutant was unable to
compete, indicating that this single-nucleotide mutation had
prevented 2A binding (Fig. 3d). Similarly, RNAs with
stem-disrupting mutations (G52U and SL30; Fig. 3c) were also
unable to compete with WT RNA (Fig. 3e), indicating that the
presence of at least part of the stem–loop duplex is also important
for 2A binding (and not just for proper positioning of
the RNA:protein complex for PRF stimulation). A direct
interaction between 2A and RNA would likely involve a cluster
of positively charged residues on 2A. By inspecting an alignment
of cardiovirus 2A sequences we identiﬁed a conserved linear basic
cluster (Supplementary Fig. 6c). We generated a recombinant
mutant 2A (hereafter 2A-mut) by changing R95 and R97 to
alanines (Supplementary Fig. 6d,e). EMSA analysis conﬁrmed
that 2A-mut was unable to bind to the EMCV PRF signal
(Fig. 3f). Further, when introduced into the virus genome, the
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R95 and R97 substitutions resulted in a protein expression
pattern similar to that of SS mutant virus, indicating that the
2A mutations had inhibited PRF (Fig. 4a–c). Consistent with
the increase in frameshifting efﬁciency, the amount of 2A in
cells infected with WT virus increases dramatically between 4 and
6 h p.i. (Fig. 4d).
Virus protein 2A trans-activates ribosomal frameshifting. Next
we asked whether the 2A protein is sufﬁcient to stimulate PRF in
the absence of viral infection. To test this we titrated recombinant
2A into a wheat germ (WG) in vitro translation system
programmed with a reporter mRNA containing the EMCV
PRF signal (Fig. 5a). Increasing amounts of 2A led to a modest
general inhibition of cap-dependent translation, as reported
previously24,25. When the reporter was translated in the absence
of 2A, only the non-frameshift product was observed (Fig. 5b,
lane DB). However, in the presence of 2A, efﬁcient PRF
was observed, to a level of B20% with increasing amounts of
2A (Fig. 5b,c). In control translations, PRF was abolished
upon mutating the frameshift site (SS), or the stem–loop and
CCC triplet (SL), or upon replacing 2A with 2A-mut (Fig. 5d).
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Changing the loop-region CCC triplet to UUU (3CU), CUC
(C46U) or CAC (C46A) also inhibited PRF (Fig. 5e). The SL50
and SL30 mutations of Figs 3c and 5a substantially reduced PRF
(to 4% and 1%, respectively) whereas the SL5030 mutations
(designed to restore the stem–loop structure but with altered base
pairings) restored PRF to WT levels (Fig. 5e). Further, increasing
(þU) or decreasing (U) the spacer length by 1 nt reduced PRF
to 6 and 1%, respectively (Fig. 5e). Similar results were observed
in the rabbit reticulocyte lysate (RRL) in vitro translation system
(Supplementary Fig. 7).
The in vitro translation systems were also used to further
investigate ribosome pausing at the frameshift site (Fig. 6 and
Supplementary Fig. 8). The extent of pausing was assessed by
comparing the levels of a translational intermediate correspond-
ing to pausing at the EMCV shift site with that of the full-length
polypeptide produced during a time course in which translation
was synchronized by the addition of edeine, a potent inhibitor of
initiation, 5min after the start of the reaction. Consistent with the
ribosome proﬁling, we observed strong pausing at a mutated
shift site (SS) in the presence of recombinant 2A (Fig. 6b and
Supplementary Fig. 8a), a much less pronounced pause at the WT
shift site (Fig. 6c and Supplementary Fig. 8b), and no pause when
the stem–loop and CCC triplet were mutated (SS-SL and WT-SL;
Fig. 6d and Supplementary Fig. 8c) or when SS or WT RNA was
translated in the presence of 2A-mut (Fig. 6e and Supplementary
Fig. 8d). Thus, both the stem–loop and 2A protein are required
for ribosome pausing. When the spacer length was increased by
1 nt (SSþU and WTþU) pausing was observed in the presence
of 2A but was much less pronounced than for SS RNA
(Supplementary Fig. 8e,f). The appearance of the pause product
is transitory (albeit spread over several minutes for WT and many
minutes for SS; Fig. 6b,c), consistent with its identity as a genuine
intermediate rather than a dead-end product. There was no
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evidence for signiﬁcant ribosomal drop-off occurring at the
WT shift site (Fig. 6c and Supplementary Fig. 8b, 60-min lane)
though we could not rule out a small amount of drop-off
occurring when the shift site was mutated due to the long half-life
of the pause product for these constructs (Fig. 6b and Suppleme-
ntary Fig. 8a).
Discussion
We have shown that PRF in EMCV is extraordinarily efﬁcient,
and, in stark contrast to other cases of  1 PRF such as from HIV
or SARS coronavirus, varies dramatically over the course
of infection from 0 to B70% and depends crucially on a
trans-activating virus protein (Fig. 7). Early in infection the
efﬁciency of PRF is negligible, allowing efﬁcient translation of the
30-encoded replication proteins. However, late in infection and
presumably as a result of increasing concentrations of cytoplas-
mic 2A, PRF becomes highly efﬁcient, resulting in 43-fold
downregulation of replication protein synthesis. This provides
an elegant and economic solution to facilitate maximal build
up of replication capacity early in infection, while providing
a translational bias that favours virion production at late
timepoints, and raises the question of whether other
‘single-polyprotein’ viruses such as poliovirus and hepatitis C
might also use non-canonical translational mechanisms to
temporally regulate replication protein synthesis. These results
provide a satisfying conclusion to observations by Paucha et al.
who, 40 years ago, observed approximately twice as much capsid
as noncapsid viral protein in EMCV-infected cells, speciﬁcally at
late timepoints. Although they could not then provide a
mechanism, these authors showed extraordinary insight—long
before the EMCV genome was sequenced—by proposing a model
in which, to quote, ‘some viral-speciﬁed protein acts as a speciﬁc
termination factor capable of causing premature termination
of translation at a site located near the midpoint of the viral
RNA’26. We can now conﬁrm that this effect is mediated at
the translational level, and depends on protein-stimulated
PRF rather than ribosomal drop-off at StopGo or at other
sites during polyprotein synthesis.
Together with  2 PRF for nsp2TF expression in members of
the family Arteriviridae, where we recently demonstrated that
PRF is critically dependent on the arteriviral protein nsp1b
and host poly(C) binding proteins interacting with a 30 C-rich
motif separated from the frameshift site by a 10-nt spacer27,
this is one of only two known cases of protein-stimulated PRF.
As 2A and nsp1b are viral proteins, they cannot be utilized for
normal cellular gene expression. Nonetheless there may be other
cases of protein-stimulated PRF and the two extant examples
suggest that the protein binding sites can be positioned just
outside the mRNA entrance channel at the onset of frameshifting.
Cellular analogues would have been missed by previous
bioinformatic searches for PRF sites that have relied on the
presence of a predicted RNA structure beginning closer to a
slippery heptanucleotide shift site28.
An association between ribosomal pausing and RNA-structure-
stimulated  1 PRF has been previously reported29–31 though it
has been unclear to what extent pausing is required for  1 PRF
as opposed to being an unavoidable side effect. Of note, several
previous pausing analyses used reporters with a mutated shift site.
Similar to recent analyses of RNA structure-stimulated  1 PRF
in a cell-free Escherichia coli system9, we observed much more
pronounced pausing when the shift site was mutated than for an
intact shift site (Supplementary Fig. 2c,d in cells and Fig. 6b,c
in vitro), suggesting that, by making a  1 nt shift, ribosomes are
able to more efﬁciently remove 2A and unwind the stem–loop
than if they remain in the original frame. Similar to that study,
but in contrast to recent single-molecule FRET work8, the EMCV
pause starts when the P- and A-sites are on the shift site, not
upstream. The reason for the signiﬁcantly lower PRF efﬁciency
observed in vitro (maximumB20%) compared to virus infection
(maximum B70%) remains unknown, but possibilities include
incomplete activity of the recombinant 2A, effects of more distal
RNA sequences, or differences in translational environment, such
as salt, temperature, pH and ribosome loading. In the absence of
authentically processed 2A, PRF in the StopGo (LV) mutants
would be stimulated by 2A–2B (or cleaved versions thereof
(ref. 17)) and/or 2A–2B* and this may explain the slightly
reduced PRF level in LV-WT (Fig. 2e). The stem–loop:2A
complex likely acts as an analogue of an RNA structure
stimulator, except that it is regulatable. At this stage it is not
known if it is simply an obstacle (e.g. to ribosome subunit
rotation) or has some more speciﬁc interaction with the
ribosome.
This report describes an example of a temporally regulated PRF
‘switch’. A second example of viral protein-stimulated PRF has
been noted recently in arteriviruses27, and an miRNA-stimulated
PRF signal has been discovered in the mRNA encoding the
HIV-1 co-receptor CCR5 (ref. 4). The recent identiﬁcation of
these unrelated examples of trans-activated PRF signals indicates
such signals may be more widespread in viruses and their hosts,
and that regulated expression through the stimulation of  1 PRF
will become an established paradigm of gene expression.
Methods
Cells, recombinant viruses and plasmids. Cell lines were obtained from the
European Collection of Authenticated Cell Cultures (ECACC) and tested for
mycoplasma by PCR (e-Myco plus Mycoplasma PCR Detection Kit; iNtRON
Biotechnology). In addition, the sequenced libraries (L929 cells) were queried for
mycoplasma sequences. WT and mutant viruses are based on the EMCV subtype
mengovirus cDNA, pMC0, developed by Ann Palmenberg (University of
Wisconsin-Madison)32. The parental (WT) sequence used is similar to GenBank
accession DQ294633.1, but a 55-nt poly(C) tract in the 50 UTR is deleted and there
are 13 single-nucleotide differences (A2669C, G3044C, C3371T, A4910C, G4991A,
C5156T, G5289A, G5314C, G5315A, A5844C, G6266A, G6990A, A6992G;
DQ294633.1 coordinates). Excepting the preceding sentence, nucleotide
coordinates are given with respect to vMC0. WT, SS and LV-WT viruses were a
kind gift from Gary Loughran (University College Cork)17,23. All constructs were
prepared by standard PCR mutagenesis and recombinant DNA techniques and
subcloned regions altered by mutagenesis were veriﬁed by DNA sequencing. All
viruses were able to replicate in cell culture. The SS and SL mutations do not alter
the polyprotein amino acid sequence.
In vitro frameshifting at the EMCV PRF signal. For in vitro frameshifting assays,
we cloned a 105-nt sequence containing the G_GUU_UUU shift site ﬂanked by
12 nt upstream and 86 nt downstream, or mutant derivatives, into the dual
luciferase plasmid pDluc at the XhoI/BglII sites33. The sequence was inserted
between the Renilla and ﬁreﬂy luciferase genes so that ﬁreﬂy luciferase expression is
dependent on  1 PRF. For ribosomal pausing analysis, the EMCV shift site
ﬂanked by 5 nt upstream and 93 nt downstream, or mutant derivatives, were cloned
into pPS0 at the XhoI/PvuII sites29. For the expression of recombinant 2A in E. coli,
the 2A coding sequence was ampliﬁed from pMC0 and cloned into pGEX-6P-2
(GE Healthcare) at the BamHI/XhoI sites. The expressed 2A, following removal of
the glutathione-S-transferase moiety by PreScission Protease (a kind gift from
Stephen Graham, University of Cambridge), has an additional 4 and 13
vector-derived residues at its N- and C-termini, respectively.
In vitro transcription and generation of recombinant virus. RNA was
transcribed using the Megascript T7 kit (Ambion) from BamHI-linearized
plasmids. Reactions were phenol/chloroform extracted, the RNA desalted by
centrifugation through a NucAway Spin Column (Ambion) and concentrated by
ethanol precipitation. Puriﬁed RNAs were used to transfect 35-mm dishes of L929
or BHK-21 cells using 1.2 mg RNA and 4 ml DMRIE-C reagent according to the
manufacturer’s instructions. Transfected cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) with high glucose and 1% fetal bovine serum (FBS) for
1–5 days depending upon how rapidly cytopathic effect developed. Cultures were
subjected to three rounds of freeze–thawing, cell debris removed by centrifugation
for 5min at 4,000g and the supernatant stored in aliquots at  80 C.
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Plaque assays. BHK-21 cells at 90% conﬂuence in six-well plates were infected
with serial dilutions of virus stocks. Cells were washed with serum-free medium,
overlaid with virus innoculum and incubated for 1 h at 37 C. Innocula were
removed and replaced with 1.5% low melting point agarose (Invitrogen) containing
DMEM plus 2% FBS. After 40 h incubation at 37 C, cells were ﬁxed with formal
saline and stained with 0.1% toluidine blue.
Metabolic labelling and calculation of PRF efﬁciencies. BHK-21 cells were
infected at a multiplicity of infection (MOI) of B10 in a volume of 150 ml
in 24-well plates. After 1 h the inoculum was replaced with 1ml DMEM containing
1% FBS. At 7 h p.i., cells were incubated for 1 h in methionine- and serum-free
DMEM, and radiolabelled from 8 to 9 h p.i. with [35S] methionine at 100 mCiml 1
(B1,100 Cimmol 1) in methionine-free medium. Cells were scraped into the
medium, pelleted at 13,000g for 1min, washed twice by resuspension in 1ml of
ice-cold phosphate-buffered saline (PBS) and pelleted for 2min at 13,000g. Cell
pellets were lysed in 35ml 4 SDS–PAGE sample buffer and boiled for 5min
before analysis by SDS–PAGE. Dried gels were exposed to X-ray ﬁlms or to
phosphorimager storage screens. Image analysis was carried out using Image-
QuantTL 7.0, and the radioactivity in virus-speciﬁc products quantiﬁed.
The intensity for each WT virus product was measured, normalized by
methionine content and then by the mean value for VP0, VP3 and VP1 to control
for lane loading. Next, to factor out differences in protein turnover besides
unquantiﬁed processing intermediates, for each biological replicate the WT values
for VP0, VP3, VP1, 2C, 3Aþ 3AB, 3Cþ 3CD and 3Dþ 3CD were normalized by
corresponding values for SS mutant virus. Then the normalized values for 2C,
3Aþ 3AB, 3Cþ 3CD and 3Dþ 3CD (i.e. products encoded downstream of the
frameshift site) were averaged and divided by the average of the values for VP0,
VP3 and VP1 (i.e. products encoded upstream of the frameshift site). This gives an
estimate of the fraction of ribosomes that avoid a  1 PRF (Fig. 4c). One minus
this value estimates the PRF efﬁciency.
Ribosome proﬁling library preparation. L929 cells in 60-mm dishes were
infected at an MOI of B10 in an initial volume of 1.5ml DMEM with 1% FBS.
After 1 h adsorption at 37 C an additional 3.5ml was added and incubation
continued. At the appropriate time points, cells were treated with cycloheximide
(Sigma-Aldrich; to 100 mgml 1; 2min). Cells were rinsed with 5ml of ice-cold
PBS, the dishes submerged in a reservoir of liquid nitrogen for 10 s, transferred to
dry ice and 400 ml of lysis buffer (20mM Tris-HCl pH 7.5, 150mM NaCl, 5mM
MgCl2, 1mM DTT, 1% Triton X-100, 100 mgml 1 cycloheximide and 25 Uml 1
TURBO DNase (Life Technologies)) dripped onto the cells. The cells were scraped
extensively to ensure lysis, collected and triturated with a 26-G needle 10 times.
Lysates were clariﬁed by centrifugation for 20min at 13,000g at 4 C, the
supernatants recovered and stored in liquid nitrogen. Cell lysates were subjected to
Ribo-Seq and RNA-Seq. The methodologies employed were based on the original
protocols of Ingolia et al.19,34, except library amplicons were constructed using
a small RNA cloning strategy35 adapted to Illumina smallRNA v2 to allow
multiplexing36. RiboZero-based rRNA subtraction was used for RNA-Seq libraries
(Epicentre, cat. no. RZH1046) while Ribo-Seq libraries were untreated. Amplicon
libraries were sequenced using the Illumina HiSeq 2000 platform at the Beijing
Genomics Institute (round 1) and the Illumina NextSeq platform at the
Department of Biochemistry, University of Cambridge (round 2). Sequencing data
have been deposited in ArrayExpress (http://www.ebi.ac.uk/arrayexpress) under
the accession number E-MTAB-5206.
Ribosome proﬁling data analysis. Adaptor sequences were trimmed using the
FASTX-Toolkit (Hannon lab) and reads shorter than 25 nt were discarded.
Trimmed reads were ﬁrst mapped to Mus musculus databases of rRNA, ncRNA
(Ensembl, GRCm38.70, ncRNA) and mRNA (NCBI RefSeq mRNAs) using bowtie
version 1 with seed length 23 and default parameters37. Remaining reads were
mapped to the relevant virus genome (EMCV or mutants thereof). To ascertain
that prior mapping to host sequences did not remove viral reads, we also tested
mapping reads to the virus genome ﬁrst, and found that the same set of reads were
identiﬁed. Supplementary Table 1 shows the composition statistics for each library.
Host mRNA RiboSeq phasing distributions (Supplementary Figs 1c and 4c)
were derived from reads mapping to the ‘interior’ regions of annotated coding
ORFs; speciﬁcally, the 50 end of the read had to map between the ﬁrst nucleotide of
the initiation codon and 30 nt 50 of the last nucleotide of the termination codon,
thus, in general, excluding RPFs of initiating or terminating ribosomes. Histograms
of inferred approximate P-site positions (50 end coordinate þ 12 nt offset) of host
mRNA RPFs relative to initiation and termination codons (Supplementary Figs 1a
and 4a) were derived from reads mapping to RefSeq mRNAs with annotated CDSs
X450 nt in length and annotated 50 and 30 UTRs X60 nt in length. All ﬁgures are
based on total numbers of mapped reads, rather than weighted sums for highly
expressed mRNAs (cf. ref. 19), because virus-induced shut-off of host cell
translation at late time points reduces the efﬁcacy of the latter approach for our
data. Read length distributions (Supplementary Figs 1b,4b and 5b) are based on
total mapped reads (to positive-sense host mRNA or EMCV genome, as indicated)
without restriction to annotated coding regions.
Plots showing RPFs mapped to the EMCV genome (Figs 1d and 2b and
Supplementary Fig. 2a) show the positions of the 50 ends of RPFs with a þ 12 nt
offset to show the approximate P-site, smoothed with a 15-nt running-mean ﬁlter.
For consistency, RNA-Seq plots (Supplementary Fig. 5) also show the positions of
the 50 ends of reads with a þ 12 nt offset. Read densities are displayed in reads per
million reads mapped to the virus positive-sense or host messenger RNA (RPM).
To calculate PRF efﬁciencies from proﬁling data, Ribo-Seq read densities
upstream and downstream of the PRF signal were determined. In this analysis,
normalization by RNA-Seq densities was not carried out as the kinetics of RNA
synthesis are not synchronous with the kinetics of RNA translation, and, especially
late in infection, newly synthesized RNA may be destined for packaging rather than
translation. Ribosome density along the virus genome may be affected by the
kinetics of translation (as newly synthesized RNA enters the translation pool it
takes 10–12min for ribosomes to reach the 30 regions38), variations in translation
speed and ribosome pausing between different genomic regions, technical biases
(nuclease, PCR, ligation)39 and potentially ribosome ‘drop-off’ at other sites along
the genome. The SS mutant was used as an appropriate control by which to
normalize the WT RPF density for these factors. PRF efﬁciencies (Figs 1e and 2e)
were calculated using RPFs with estimated P-sites mapping within the regions
180 nt after the polyprotein initiation codon to 180 nt upstream of the junction
between the 2A and 2B coding regions (upstream density), and 180 nt downstream
of the 2B* stop codon to 180 nt upstream of the polyprotein stop codon
(downstream density). RPF counts were divided by region lengths to obtain RPF
densities. To calculate the fraction of ribosomes that avoid a  1 PRF, the
downstream mean density was divided by the upstream mean density, and this
value for WT or mutant viruses was divided by the corresponding value for the SS
mutant. One minus this value estimates the PRF efﬁciency.
For phasing histograms (Figs 1f and 2d and Supplementary Fig. 2e), RPF
densities were calculated for each of the three phases (based on RPF 50 end position
within polyprotein-frame codons), for RPFs with estimated P-sites mapping within
each of the three regions: from 30 nt after the polyprotein initiation codon to 30 nt
upstream of the junction between the 2A and 2B coding regions (upstream region);
from 15 nt downstream of the shift site to 15 nt upstream of the 2B* stop codon
(overlap region); and from 30 nt downstream of the 2B* stop codon to 30 nt
upstream of the polyprotein stop codon (downstream region). RPF counts were
then normalized by the length of the relevant region, and by the total number of
counts mapping to all three regions.
To estimate the length of pausing at the mutated shift site we compared the SS
and SS-SL mutants of Fig. 2b. In the ﬁrst round ribosomal proﬁling, the pausing
peak extended over four codons starting at the shift site (Supplementary Fig. 2d)
whereas in the second round ribosomal proﬁling, it was spread over B20 codons,
indicating considerable ribosome run-on during preparation of the latter
samples22. RPF histograms for SS and SS-SL were ﬁrst normalized by the total
number of RPFs with estimated P-sites mapping within the regions 180 nt after the
polyprotein initiation codon to 180 nt upstream of the junction between the 2A and
2B coding regions or 180 nt downstream of the 2B* stop codon to 180 nt upstream
of the polyprotein stop codon (Fig. 2c). Then the RPF density was summed over
the 20 codons starting from the shift site. Within these 20 codons, SS-SL had a
mean normalized RPF density of 0.80 while SS had a mean normalized RPF
density of 5.10. Under the assumption that the SS-SL value reﬂects the effect of
local technical biases (PCR, ligation, nuclease), the excess density in SS is
20 (5.10/0.80 1)¼ 107.5, which, assuming a mean translation time of 0.18 s
codon 1, equates toB20 s. This calculation is approximate as the underlying RPF
distributions over these 20 codons differ between SS (mostly run-on of ribosomes
initially paused at the shift site) and SS-SL (codon-speciﬁc variability in decoding
times) so that an attempt to factor out technical biases via the quotient SS/SS-SL is
inherently ﬂawed. Further, it is also possible that pausing may be underestimated if
the 30-adjacent stem–loop and/or bound 2A inhibits nuclease cleavage at the
leading edge of the ribosome and the production of appropriately sized RPFs for
some fraction of ribosomes paused on the shift site.
Structure probing. Short, 33P-labelled RNAs (111 nt) containing the EMCV PRF
region (shift site plus 32 nt upstream and 72nt downstream) were prepared by T7
transcription of a PCR product generated using primers ﬂanking the PRF region,
with the 50 primer containing the T7 polymerase promoter sequence. Transcripts
(5mg) were dephosphorylated with Antarctic phosphatase according to the
manufacturer’s recommendation (New England BioLabs) and 50 end-labelled using
polynucleotide kinase at 37 C for 1 h in a reaction containing 20mCi [g-33P]ATP
(10mCiml 1 stock; PerkinElmer), 50mM Tris pH 7.5, 10mM MgCl2 and 5mM
dithiothreitol. The labelled RNA was loaded onto a 10% acrylamide-urea denaturing
gel, full-length RNA eluted from the gel slice in 0.5M NH4OAc, 10mM MgOAc,
1mM ethylenediaminetetraacetic acid (EDTA) and 0.1% SDS and concentrated by
ethanol precipitation. RNA structure probing reactions were performed in a ﬁnal
volume of 50ml containing B20,000 c.p.m. 50 [33P] end-labelled transcript, 2mM
MgCl2, 10mg pig liver rRNA and the relevant enzymatic or chemical probe40.
Products were analysed on a 10% acrylamide/7M urea gel.
RiboTrap and mass spectrometry. RNA-binding proteins that may associate
with the EMCV PRF signal were screened using the RiboTrap method using
a commercial kit (RiboCluster Proﬁler RiboTrap Kit; Medical & Biological
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Laboratories, Japan)41. WT and scrambled EMCV RNA baits were generated by
in vitro transcription from plasmid pBKS/EMCV, which contains 126 nt of EMCV
sequence beginning immediately 30-adjacent to the G_GUU_UUU shift site.
The 145-nt T7 transcript generated from this vector comprises 126 nt of virus
sequence ﬂanked by vector sequences at 50 (GGGCGAAUUGGAGCU) and
30 (AAUU) ends. For the scrambled version, the WT stem–loop sequence CG GCA
GTG TCA TCA ATG GCT CAA ACC CTA CTG CCG was changed to GA GAA
AAC CGC CAC TTC CGA CGC TCG TGT ATG CTC. For generation of
Br-U-labelled RNA transcripts, transcription reactions contained a 2:1 ratio
of UTP:Br-UTP.
Cell lysates were prepared from 20 T160 ﬂasks of BHK-21 cells infected with
EMCV WT at MOI B10, or mock infected. Cells were scraped into the medium,
collected by centrifugation at 300g for 5min at 4 C and washed three times with
ice-cold PBS before resuspension in 2,400 ml of RiboTrap CE buffer supplemented
with DTT to a ﬁnal concentration of 1.5mM. The lysate was incubated on ice for
10min, 120 ml of RiboTrap Detergent solution added and the tubes inverted gently
ﬁve times. The lysate was centrifuged immediately for 5min at 3,000g to precipitate
the nuclei. Seventy-two microlitres of RiboTrap High-Salt solution was added to
the tube, mixed gently and centrifuged at 12,000g for 3min at 4 C. The
supernatant was retained and used immediately in the RiboTrap assay.
RNA-binding proteins associated with the target RNA were analysed by
SDS–PAGE on a 4–20% tris-glycine gel. Coomassie blue-stained products were
excised from the gel and subjected to in-gel trypsin digestion. Peptides were
extracted and analysed by liquid chromatography tandem mass spectrometry
(LC-MS/MS). Fragment MS/MS spectra were searched with the MASCOT search
engine (Matrix Science) against a protein sequence database composed of expected
viral target sequences, cellular proteins and common contaminant proteins.
Protein expression and puriﬁcation. N-terminally glutathione-S-transferase-
tagged proteins were puriﬁed from E. coli BL21/DE3/pLysS cells. Single colonies
were picked into Luria-Bertani broth and grown at 37 C to an OD600 of 0.6.
Protein expression was induced by addition of isopropyl b-D-1-thiogalactopyr-
anoside (to 0.1mM) and continued for 2 h at 37 C (or overnight at 22 C) after
which cells were pelleted and resuspended in lysis buffer (1.4mM -mercap-
toethanol, 0.5mM MgCl2, 0.05% Tween 20, 0.02 M Tris pH 7.5, 150mM NaCl,
DNase 1Uml 1 and protease inhibitor 1Uml 1). Cells with protease inhibitor
cocktail (Sigma) and DNase (Sigma) were incubated on ice for 30min and
sonicated to complete lysis. Proteins were puriﬁed using glutathione agarose resin
(GE Healthcare) according to the standard procedures42, then dialysed against
50mM Tris, pH 7.5, 100mM KCl, 1mM dithiothreitol (DTT), 0.05mM EDTA
and 5% glycerol, quantiﬁed by Bradford assay (ThermoFisher Scientiﬁc), and
stored at  80 C until required.
Immunoblotting. Infected cell lysates or puriﬁed proteins were separated on
15% acrylamide/bisacrylamide gels (BioRad mini-protean tetra cell apparatus) and
transferred to nitrocellulose membranes for 120min using a mini-protean transblot
cell and Tris glycine transfer buffer. Following blocking with 5% non-fat milk,
primary antibody incubations were carried out overnight at 4 C using 1:1,000
diluted anti-2A (rabbit polyclonal raised against the C-terminal 14 aa of 2A by
GenScript) or anti-tubulin (rat monoclonal; Abcam, ab6160) antibodies. Secondary
antibody was the appropriate IRDye-conjugate (Li-Cor) used at 1:10,000 dilution.
All washes employed PBS containing 0.1% Tween 20. Blots were scanned on a
Licor Odyssey infrared scanner.
Electrophoretic mobility shift assay. Short, 32P-labelled template RNAs (64 nt)
containing the EMCV PRF region (with slippery sequence precisely at the 50 end)
were prepared by T7 transcription of a PCR product generated using primers
ﬂanking the PRF region, with the 50 primer containing the T7 polymerase
promoter sequence. Radiolabelled RNAs were mixed with test proteins in 10 ml
reactions in EMSA buffer (10mM Hepes pH 7.6, 150mM KCl, 2mMMgCl2, 1mM
DTT, 0.5mM adenosine triphosphate, 5% glycerol, 100 mgml 1 porcine tRNA,
10U RNase inhibitor ml 1). Test proteins were diluted in dilution buffer (DB)
(5mM Tris pH 7.5, 100mM KCl, 1mM DTT, 0.05mM EDTA, 5% glycerol).
For competition experiments, unlabelled competitor RNA was incubated with WT
32P-labelled RNA and 2A (1.8 mM). Reactions were incubated at 30 C for 10min
before promptly loading the mix onto 4% acrylamide non-denaturing gels
(acrylamide:bisacrylamide ratio 10:1). Gels were run at 175V at room temperature
until free and bound RNA species were resolved, then ﬁxed for 15min in
10% acetic acid, 10% methanol, dried and exposed to X-ray ﬁlm and phosphor-
imager screen.
In vitro translation. Frameshift reporter plasmids were linearized with FspI
and capped run-off transcripts generated using T7 RNA polymerase43.
Messenger RNAs were translated in nuclease-treated RRL or WG extracts
(Promega) programmed with B50mgml 1 template mRNA. Typical reactions
were of 10 ml volume and composed of 90% (v/v) RRL, 20 mM amino acids
(lacking methionine) and 0.2 MBq [35S]-methionine. Reactions were incubated for
1 h at 30 C and stopped by the addition of an equal volume of 10mM EDTA,
100mgml 1 RNase A followed by incubation at room temperature for 20min.
Proteins were resolved by 12% SDS–PAGE and dried gels were exposed to X-ray
ﬁlm or to a Cyclone Plus Storage Phosphor Screen (PerkinElmer). The screen was
scanned using a Typhoon TRIO Variable Mode Imager (GE Healthcare) in storage
phosphor autoradiography mode and bands were quantiﬁed using
ImageQuantTL software (GE Healthcare). PRF efﬁciencies were calculated as
[IFS/MetFS]/[IS/MetSþ IFS/MetFS], where the number of methionines in the stop
and frameshift products are denoted by MetS and MetFS, respectively, and the
densitometry values for the same products are denoted by IS and IFS, respectively.
All frameshifting assays were performed at least three times.
Ribosome pausing assays. WG and RRL in vitro translation reactions (30 ml)
were supplemented with 1 mM of 2A, 2A-mut or dialysis buffer, and programmed
with mRNAs derived from AvaII-cut pPS-EMCV-WT or mutant derivatives.
Reactions were incubated at 26 C for 5min prior to the addition of edeine to 5 mM
ﬁnal concentration. Aliquots (1.5 ml) were subsequently withdrawn at set intervals
post-edeine addition, mixed with an equal volume of 100 mgml 1 RNase A in
10mM EDTA and placed on ice. At the end of the time-course, products were
resolved by 12% SDS–PAGE. The expected size of the ribosomal pause product was
marked by translating a control mRNA produced from XhoI-cleaved pPS0.
Data availability. Sequencing data have been deposited in ArrayExpress
(http://www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-5206.
The data that support the ﬁndings of this study are available from the
corresponding author upon request.
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